explore -WSS

explore

author：leisure time 2025-08-31 01:59:46 - browse：643

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Medicare explains how it will choose drugs for negotiation

explore

WSS

Drug firms test therapies to halt Alzheimer’s before symptoms arise

How to make AI work for medicine

Future doctors should be trained to promote social change

Nurses recount patients attacks

Drug firms test therapies to halt Alzheimer’s before symptoms arise

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

knowledge

explore

explore

Moonlake's readout produced a cash windfall. Risks remain

Gene editing the human germline: What are the risks?

23andMe had bad news about my health. I wish a person had delivered it

Stop the failed accountable care organization experiment

The high cost of giving birth even with insurance

Why more medical students aren't specializing in primary care

Novavax promises a turnaround & Lilly roils the obesity market

How Long Island became the ‘eugenics capital of the world’

Medical leaders decry Supreme Court decision on affirmative action

Future doctors should be trained to promote social change

entertainment

Intermittent fasting comes with a heart risk? Not so fast

FDA panel gives mixed vote on blood pressure devices

Physicians and social media: If you see something, say something?

Radiation, mainstay of cancer treatment, begins a fade

Winners, losers from Medicare’s list of drugs subject to price talks

Orchard's therapy for neuron disease in children wins FDA approval

knowledge

explore

focus

explore